Global Nuclear Medicine Market to Reach US$ 7.09 Billion by 2020

2026-07-07 05:11:32 Health and Fitness

746

According to a new research report by RNCOS entitled, ?Global Nuclear Medicine Outlook 2020?, the Nuclear Medicine has seen increased adoption over the past few years and is continuously gaining popularity among healthcare providers by playing a significant role in clinical decision making for disease diagnosis as well as treatment. The market is expected to witness robust growth in the years to come, surging from US$ 4.20 Billion in 2014 to US$ 7.09 Billion in 2020 at a CAGR of 9%.

Based on the application, the Nuclear Medicine market is categorized into Diagnostics and Therapeutics market. Nuclear Medicine Diagnostics, consisting of imaging modalities (SPECT and PET) and diagnostic radiopharmaceuticals, accounted for the largest share in the total market during 2014. However, with the advancement in alpha emitting radiopharmaceuticals and introduction of targeted therapies for cancers, the therapeutics market is likely to drive the future growth of the Nuclear Medicine market. Geographically, the US is the largest consumer of Nuclear Medicine technologies followed by the Europe and Asia-Pacific. However, emerging economies in the Asia-Pacific region represents the most lucrative markets in the coming years.

Research Analysis and Highlights

The report spans over 65 pages and provides an overview of the Global Nuclear Medicine market. The report highlights market segmentation of the industry by applications and geography. The report provides in-depth analysis of the market segments along with the factors driving the industry growth, and challenges faced by the industry. In addition to this, the study includes an analysis of the recent trends and developments in the Global Nuclear Medicine market. With special emphasis on the competitive landscape and dominant players in the market, the research provides valuable information to the investors who are looking to enter in this market.

Some of the key highlights of the report include the following:

? Nuclear Medicine Therapeutics to drive the Nuclear Medicine market
? Hybrid imaging propelling growth in Nuclear Medicine market
? Efforts underway to overcome Molybdenum-99 supply shortage

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM797.htm

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

ABOUT RNCOS

RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.